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Available online 2 April 2016Vitamin D is a key player in the endocrine regulation of calcium and phosphate metabolism and plays a pivotal
role in the acquisition of bonemass during childhood. This study investigated long-term data of vitamin D levels
in children and adolescents between 1 and 18 years of age. Serum 25-hydroxyvitamin D (25(OH)D) was ana-
lyzed between 1982 and 2013 in 2048 Swedish Caucasian children (mean age ± SD, 8.59 ± 3.68 years; 1197
boys). Overall, 704 (34%) children had below recommended levels of 50 nmol/L; however, only 63 (3%) had
levels below 25 nmol/L, i.e., vitamin D deﬁciency. No trend for decreased vitamin D levels over time was found
in this population,withmedian 25(OH)D levels of 58.4 nmol/L,minimum–maximum5.0–159.3 nmol/L. Younger
children, independent of gender, had signiﬁcantly higher levels 25(OH)D.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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TrendThe importance of vitamin D for skeletal health is well established
and its potential role in extraskeletal health has generated much inter-
est in recent years. A recent umbrella review summarized that vitamin
D deﬁciency is linked to an array of chronic diseases, e.g., diabetes, auto-
immunity, cancer, and is associated with negative cardiovascular out-
comes (Theodoratou et al., 2014). Data from a large study
demonstrated a J-shaped association of all-cause mortality with serum
25-hydroxyvitamin D (25(OH)D), and the lowest mortality risk was at
50–60 nmol/L (Durup et al., 2012). Vitamin D status is deﬁned by
serum 25(OH)D, and a concentration of 50 nmol/L (20 ng/mL) cover
the requirements in 97.5% of the population (Ross et al., 2011). Solar
UV-B radiation is important for endogenous vitamin D synthesis; how-
ever, sunlight is limited at the latitude 55–69 during October to
March,(van Schoor & Lips, 2011) but Swedish children generally have
a high intake of vitamin D from dietary products.
We hypothesized that the generally increased indoor activities
would contribute to decreased vitamin D levels in children over the
years. The present study provided long-term data of vitamin D levelsgy/Endocrinology, Institute of
y at University of Gothenburg,
lbertsson-Wikland).
en access article under the CC BY-NCin a group of children between 1 and 18 years of age referred over
30 years for extensive growth evaluation to Göteborg Pediatric Growth
Research Center (GP-GRC), whowere diagnosed with short stature due
either to idiopathic or organic cause of growth hormone (GH) insufﬁ-
ciency, to decreased GH responsiveness as in children with idiopathic
short stature, born small for gestational age or childrenwith syndromes
or chronic diseases; and also healthy children with normal or tall
stature.
Serum 25(OH)D was analysed between 1982 and 2013 in 2048
Swedish Caucasian children (mean age ± SD, 8.59 ± 3.68 years; 1197
boys)with the IDS-iSYS 25-Hydroxy Vitamin DS automated chemilumi-
nescence immunoassay (Immunodiagnostic Systems Limited, Boldon,
UK) at the GP-GRC laboratory (Swedac accredited no. 1899). The
intra-assay and interassay coefﬁcients of variation were 2.5% at
50.1 nmol/L and 9.0% at 55.0 nmol/L, respectively. All samples in the
present study were stored at−80 °C and assayed with reagents from
the same batch in days after each other. In general, serum 25(OH)D is
regarded as a stable analyte over time (Bailey et al., 2013; Stepman
et al., 2011), and studies of 40-year-old sera have revealed that
25(OH)D can be quantiﬁed to reveal potential trends that can be used
to explore vitamin D-related hypotheses (Bodnar et al., 2009). Taken to-
gether, we conclude that our 25(OH)D levels, sampled over a 30-year
period, are reliable even if the possibility exists that the 25(OH)D levels
could change during long-term storage never can be ruled out.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Yearly average values of 25(OH)D from 1982 to 2013.
25(OH)D (nmol/L)
Year Median Min Max
1982 75.0 61.8 88.1
1983 53.2 39.5 99.2
1984 62.2 27.6 108.4
1985 58.4 24.7 103.9
1986 50.8 28.0 122.8
1987 47.9 14.5 113.1
1988 54.2 18.4 115.4
1989 56.6 13.5 111.8
1990 53.7 23.5 134.8
1991 67.3 19.3 130.8
1992 59.2 12.6 149.2
1993 52.4 21.1 129.4
1994 58.6 15.3 111.5
1995 46.8 13.8 136.5
1996 52.5 18.5 103.0
1997 61.4 13.0 145.1
1998 53.8 15.6 108.6
1999 52.3 15.9 106.5
2000 57.4 19.6 103.1
2001 56.1 12.9 113.5
2002 71.9 20.2 120.0
2003 71.4 24.6 159.3
2004 68.0 16.6 138.2
2005 59.7 13.0 133.7
2006 62.3 25.0 109.4
2007 65.0 21.8 119.6
2008 72.8 29.9 128.1
2009 78.6 38.5 107.6
2010 62.0 14.1 87.1
2011 63.3 5.0 103.1
2012 61.4 23.8 119.0
2013 48.4 26.9 63.9
Fig. 1. Serum 25(OH)D levels in 2048 Swedish children over 32 years. Upper panel:
Calendar years, 1982–2013, versus 25(OH)D levels. Median (black line) and 95%
conﬁdence intervals (for each year) are shown in 2048 Swedish children, 1197 boys
(blue squares) and 851 girls (red circles). Black dotted horizontal lines represent
25(OH)D levels at 25, 50, 100 and 125 nmol/L. Above 125 nmol/L, n = 15 (1%); 100–
125 nmol/L, n = 68 (3%); 75–99 nmol/L, n = 377 (18%); 50–74 nmol/L, 884 (43%), 25–
49 nmol/L, n = 641 (31%); below 25 nmol/L, n = 63 (3%). Lower panel: Age versus
25(OH)D levels. Data represent median and 95% conﬁdence intervals for 1197 boys
(blue line; squares) and 851 girls (red line; circles). There was a signiﬁcant decreasing
trend with age independent of gender, p b 0.00001. Black dotted horizontal lines
represent the recommended 25(OH)D level of 50 nmol/L.
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sented in Table 1. No trend for decreased vitamin D levels over time
was found, with median 25(OH)D levels of 58.4 nmol/L, minimum–
maximum 5.0–159.3 nmol/L (Fig. 1, upper panel). We found a signiﬁ-
cant association (p b 0.00001) with age independent of gender,
i.e., younger children had higher 25(OH)D levels, possibly due to the
general supplementation of vitamin D recommended for Swedish in-
fants (Fig. 1, lower panel). To analyze a possible general trend in
25(OH)D, linear regression was performed to represent the moving av-
erage over the 30 years. Themonthly averages for 25(OH)Dwere calcu-
lated from March 1982 to January 2013 (n = 325). A linear regression
modelwasﬁtted to the datawith the dependent variable beingmonthly
average of 25(OH)D adjusted for age under 5 years and the independent
variable being time. No trend for 25(OH)D was found (r2 = 0.0352, p-
value =0.7507).
Overall, 704 (34%) children had below recommended levels of
50 nmol/L, and 63 (3%) had levels below 25 nmol/L, i.e., vitamin D deﬁ-
ciency (Ross et al., 2011). Less attention has been given to recommend
an upper limit of serum 25(OH)D; however 83 (4%) subjects had
25(OH)D levels above 100 nmol/L of whom 15 (1%) had levels above
125 nmol/L (Ross et al., 2011).
The presence of 3-epi-25(OH)D, a vitamin Dmetabolite with report-
ed reduced biological activity, has been reported to be a source of ana-
lytical variance in immunoassays (Bailey et al., 2013). In addition, an
age-dependent concentration has also been reported (Stepman et al.,
2011). The cross-reactivity for 3-epi-25(OH)D is approximately 1% in
the automated IDS-iSYS immunoassay used in the current study. Thus,
due to the low cross-reactivity, we do not believe that potential
amounts of 3-epi-25(OH)D overestimates the reported 25(OH)D values
in this study.
In conclusion,we found no trend for decreased vitamin D levels over
time in this Swedish population. These results will broaden ourunderstanding of the public health relevance of vitamin D and be of
value for future cost–beneﬁt analyses in preventive healthcare.Declaration of interests
We declare no competing interests.
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